These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 29728903)

  • 1. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis.
    Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K
    Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Ahmed S; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2018 Nov; 46(4):440-450. PubMed ID: 30117036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies.
    Ma Y; Xiang H; Busse JW; Yao M; Guo J; Ge L; Li B; Luo X; Mei F; Liu J; Wang Y; Liu Y; Li W; Zou K; Li L; Sun X
    J Neurol; 2024 May; 271(5):2309-2323. PubMed ID: 38436679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenecteplase versus alteplase in stroke thrombolysis: An individual patient data meta-analysis of randomized controlled trials.
    Huang X; MacIsaac R; Thompson JL; Levin B; Buchsbaum R; Haley EC; Levi C; Campbell B; Bladin C; Parsons M; Muir KW
    Int J Stroke; 2016 Jul; 11(5):534-43. PubMed ID: 27048693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
    Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
    Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials.
    Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z
    Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Logallo N; Novotny V; Assmus J; Kvistad CE; Alteheld L; Rønning OM; Thommessen B; Amthor KF; Ihle-Hansen H; Kurz M; Tobro H; Kaur K; Stankiewicz M; Carlsson M; Morsund Å; Idicula T; Aamodt AH; Lund C; Næss H; Waje-Andreassen U; Thomassen L
    Lancet Neurol; 2017 Oct; 16(10):781-788. PubMed ID: 28780236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial.
    Kvistad CE; Næss H; Helleberg BH; Idicula T; Hagberg G; Nordby LM; Jenssen KN; Tobro H; Rörholt DM; Kaur K; Eltoft A; Evensen K; Haasz J; Singaravel G; Fromm A; Thomassen L
    Lancet Neurol; 2022 Jun; 21(6):511-519. PubMed ID: 35525250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tenecteplase in comparison to alteplase in acute ischemic stroke: A systematic review and meta-analysis of randomized controlled trials.
    Salamatullah HK; Bashrahil B; Alghamdi AM; Alsharm FS; Alkulli OA; Alzahrani Z; Alkhiri A; Alghamdi S; Makkawi S
    Clin Neurol Neurosurg; 2023 Oct; 233():107961. PubMed ID: 37713743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Menon BK; Buck BH; Singh N; Deschaintre Y; Almekhlafi MA; Coutts SB; Thirunavukkarasu S; Khosravani H; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar J; Williams H; Field TS; Manosalva A; Siddiqui M; Zafar A; Imoukhuede O; Hunter G; Demchuk AM; Mishra S; Gioia LC; Jalini S; Cayer C; Phillips S; Elamin E; Shoamanesh A; Subramaniam S; Kate M; Jacquin G; Camden MC; Benali F; Alhabli I; Bala F; Horn M; Stotts G; Hill MD; Gladstone DJ; Poppe A; Sehgal A; Zhang Q; Lethebe BC; Doram C; Ademola A; Shamy M; Kenney C; Sajobi TT; Swartz RH;
    Lancet; 2022 Jul; 400(10347):161-169. PubMed ID: 35779553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of intravenous thrombolysis with tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis.
    Wei H; Fu B; Yang C; Huang M
    Neurol Sci; 2023 Sep; 44(9):3005-3015. PubMed ID: 37061572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenecteplase in ischemic stroke offers improved recanalization: Analysis of 2 trials.
    Bivard A; Huang X; Levi CR; Spratt N; Campbell BCV; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
    Neurology; 2017 Jul; 89(1):62-67. PubMed ID: 28576782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenecteplase versus alteplase for patients with acute ischemic stroke: a meta-analysis of randomized controlled trials.
    Zhang X; Wan TF; Chen J; Liu L
    Aging (Albany NY); 2023 Dec; 15(24):14889-14899. PubMed ID: 38149983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety outcomes of Tenecteplase versus Alteplase for thrombolysis of acute ischemic stroke: A meta-analysis of 9 randomized controlled trials.
    Wang Y; Cai X; Fang Q; Zhu J
    J Neurol Sci; 2024 Mar; 458():122912. PubMed ID: 38325064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, parallel group, open-label trial.
    Muir KW; Ford GA; Ford I; Wardlaw JM; McConnachie A; Greenlaw N; Mair G; Sprigg N; Price CI; MacLeod MJ; Dima S; Venter M; Zhang L; O'Brien E; Sanyal R; Reid J; Sztriha LK; Haider S; Whiteley WN; Kennedy J; Perry R; Lakshmanan S; Chakrabarti A; Hassan A; Marigold R; Raghunathan S; Sims D; Bhandari M; Wiggam I; Rashed K; Douglass C;
    Lancet Neurol; 2024 Nov; 23(11):1087-1096. PubMed ID: 39424558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial.
    Wang Y; Li S; Pan Y; Li H; Parsons MW; Campbell BCV; Schwamm LH; Fisher M; Che F; Dai H; Li D; Li R; Wang J; Wang Y; Zhao X; Li Z; Zheng H; Xiong Y; Meng X;
    Lancet; 2023 Feb; 401(10377):645-654. PubMed ID: 36774935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial.
    Bivard A; Zhao H; Churilov L; Campbell BCV; Coote S; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski AH; Dos Santos A; Ng JL; Yogendrakumar V; Ng F; Langenberg F; Easton D; Warwick A; Mackey E; MacDonald A; Sharma G; Stephenson M; Smith K; Anderson D; Choi P; Thijs V; Ma H; Cloud GC; Wijeratne T; Olenko L; Italiano D; Davis SM; Donnan GA; Parsons MW;
    Lancet Neurol; 2022 Jun; 21(6):520-527. PubMed ID: 35525251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials.
    Abuelazm M; Seri AR; Awad AK; Ahmad U; Mahmoud A; Albazee E; Kambalapalli S; Abdelazeem B
    J Thromb Thrombolysis; 2023 Feb; 55(2):322-338. PubMed ID: 36449231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.